One of India's solutions to get lower-cost meds for its impoverished and uninsured<span style="font-size: 13px;">–compulsory licenses–has ignited drugmakers' ire. And with an Indian committee currently assessing a batch of patented drugs as compulsory licensing candidates, the U.S. is fighting back–politely, at least so far.</span>
written on 06.03.2014